Heart Institute Research

badge 1

Le Bonheur's Heart Institute is at the forefront of research for children with a variety of heart conditions including the latest methods of PDA closure, cardio-oncology and the effects of chemotherapy on the heart and the genetic factors of cardiomyopathy. We are committed to finding the latest therapies and breakthroughs for children with congenital heart defects.

heart research

Our Research

  • Outcomes in children with left ventricular (LV) noncompaction
  • Mitral valve function in LV noncompaction
  • Electrophysiological aspects of LV noncompaction
  • Genetic and mechanistic basis of LV noncompaction
  • Genetic and mechanistic basis of arrhythmogenic cardiomyopathies
  • Electrophysiological aspects of arrhythmogenic cardiomyopathies: molecular basis
  • Renal function monitoring in heart transplant patients: Is cystatin C a better biomarker than creatinine?
  • The role of viral genome in the heart of transplant patients and rejection and coronary vasculopathy
  • Discovery of common biomarkers in cardiac and skeletal myopathy

Clinical Trials

If you are interested in participating in a cardiology clinical trial, please view our list of current and active trials.

Recent Publications

Related Articles

publication issue image
Gosain, Towbin Receive NIH R01 Grants

Le Bonheur Pediatric Surgeon Ankush Gosain, MD, PhD, and Cardiology Chief and Heart Institute Execut...

publication issue image
Early PDA closure may improve outcomes in preterm infants

Le Bonheur cardiologists evaluate the benefits of PDA closure prior to 4 weeks of age...

publication issue image
Competition after COVID-19

Cardiologists show heart damage in athletes unlikely after COVID-19 infection...